Pengobatan kompleks retinoblastoma Dokter Terbaik - TOP-7 dokter

Konten memenuhi Kebijakan Editorial Bookimed dan ditinjau secara medis oleh

Fahad Mawlood

Mustafa Solak

  • 4.6 Sangat baik 200 ulasan
  • 19 tahun pengalaman
  • Turquia, Istambul, Hisar Hospital Intercontinental
  • Dr. Mustafa Solak adalah seorang dokter onkologi medis dengan keahlian dalam kanker payudara, testis, ovarium, paru-paru, kepala-leher, dan saluran pencernaan. Ia lulus dari Fakultas Kedokteran Universitas Hacettepe. Ia menyelesaikan program residensinya di Rumah Sakit Pengajaran dan Penelitian Istanbul Sisli Etfal. Ia kemudian melanjutkan program fellowship di Institut Kanker Universitas Hacettepe.

    Dr. Solak telah menangani banyak kasus kanker yang kompleks. Ia telah berkontribusi pada kemajuan klinis di pusat-pusat terkemuka, termasuk University of Texas MD Anderson Cancer Center. Ia juga pernah bekerja di Rumah Sakit Pelatihan Hitit University Corum dan Rumah Sakit Medical Park. Pengalamannya menunjukkan komitmen yang kuat terhadap perawatan dan penelitian kanker.

  • Baca selengkapnya
Kunjungan dokter
Harga berdasarkan permintaan
Info

Muhammet Derda Ozer

  • 5 Sangat baik 4 ulasan
  • 21 tahun pengalaman
  • 25000+ tindakan dilakukan
  • Turquia, Istambul, Associate Professor M. Derda Ozer DERDA SAGLIK HIZMETLERI
  • Pendidikan :

    Universitas Istanbul, Fakultas Kedokteran Istanbul, September 2004 – Juli 2010

    Universitas Istanbul, Fakultas Kedokteran Istanbul, Departemen Ortopedi, Residen Februari 2011 - April 2011

    Universitas Istanbul, Fakultas Kedokteran Istanbul, Departemen Oftalmologi, Residen Agustus 2011 - Maret 2016

    Universitas Thomas Jefferson, Wills Eye Institute, Departemen Onkologi Okular, Pengamatan Agustus 2012 - September 2012

    Kementerian Kesehatan Turki, Rumah Sakit Negara Hakkari, Klinik Oftalmologi, Dokter Spesialis Mata Juli 2016 – Maret 2018

    Universitas Van Yuzuncu Yil, Fakultas Kedokteran, Departemen Oftalmologi, Asisten Profesor, Maret 2018 – Oktober 2021

    Universitas Van Yuzuncu Yil, Fakultas Kedokteran, Departemen Oftalmologi, Profesor Madya, Oktober 2021 – Desember 2021

    Universitas Istanbul Yeni Yuzyil, Fakultas Kedokteran, Departemen Oftalmologi, Profesor Madya, Januari 2022 – sekarang

    Kualifikasi Pendidikan :

    1. Penilaian ilmu dasar oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada April 2017

    2. Ujian Optik & Refraksi International Council of Ophthalmology (ICO) lulus pada April 2017

    3. Ujian Ilmu Klinis dalam Oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada April 2018

    4. Menerima beasiswa ICO-STAAR Bedah Tiga Bulan dalam Vitreo-Retina di University of Kansas, Fakultas Kedokteran, Departemen Oftalmologi di Prairie Village, KS, Amerika Serikat di bawah pengawasan Prof. Radwan Aijlan dari 6 April 2020 hingga 5 Juli 2020.

    5. Ujian Lanjutan dalam Oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada Juli 2020.

    6. United States Medical Licensing Examination (USMLE) Step 1 lulus pada 7 Januari 2021 dengan 221 poin.

    7. United States Medical Licensing Examination (USMLE) Step 2 CK lulus pada 25 Agustus 2021 dengan 214 poin.

    Presentasi & Poster :

    1. Kongres Oftalmologi Nasional ke-47, Efektivitas terapi fotodinamik pada hemangioma koroid sirkumsirkum, Presentasi lisan, Ozer MD, Tuncer S, November 2013, Antalya, Turki.

    2. Kongres Oftalmologi Nasional ke-48, Fitur klinis dan hasil pengobatan rhabdomyosarcoma oftalmik primer: Pengalaman pusat tersier, Ozer MD, Ulas MG, Tuncer S, Presentasi lisan, November 2014, Antalya, Turki

    3. Pertemuan ISOO 2015, Hasil Jangka Panjang Terapi Kombinasi (Suntikan Perilesional dan Topikal) Interferon Alpha-2b dalam Manajemen Neoplasia Skuamosa Permukaan Mata, Tuncer S, Ozer MD, Presentasi lisan, Juni 2015, Paris, Prancis

    4. Kongres Oftalmologi Nasional ke-49. Pola presentasi klinis sindrom Vogt-Koyanagi-Harada pediatrik dan hasil tindak lanjut jangka panjang, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Presentasi lisan, November 2015, Istanbul, Turki.

    5. Kongres Oftalmologi Nasional ke-49, Ketebalan kornea sentral dan dimensi cakram optik pada pasien glaukoma, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turki.

    6. Kongres Oftalmologi Nasional ke-49, Analisis lapisan serat saraf retina dan ketebalan koroid pada pasien dengan sklerosis sistemik untuk mengidentifikasi faktor risiko potensial untuk glaukoma tekanan normal, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turki.

    7. Kongres Oftalmologi Nasional ke-50, Pengobatan degenerasi makula terkait usia dengan Ranibizumab intravitreal: Pengalaman kehidupan nyata, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Presentasi lisan, November 2016, Antalya, Turki

    8. Kongres Oftalmologi Nasional ke-51, Komplikasi jarang terlihat dari operasi katarak: Hematoma Endokapsular, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turki

    9. Kongres Oftalmologi Nasional ke-52, Nanophthalmos dengan Lipatan Makula, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turki

    10. Kongres Oftalmologi Nasional ke-52, Fitur Klinis dan Metode Pengobatan Kasus Selulitis Orbital, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turki

    11. Kongres Oftalmologi Nasional ke-52, Seri Kasus: Luka Bakar Kimia Mata, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turki

    12. Kongres Oftalmologi Nasional ke-52, Kehilangan Pendengaran Sensorineural yang Mempengaruhi Frekuensi Rendah pada Pasien dengan Pseudoeksfoliasi, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turki

    13. Kongres Oftalmologi Nasional ke-52, Intubasi tabung silikon oleh stent Ritleng pada anak-anak di atas dua tahun dengan obstruksi saluran nasolakrimal, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turki

    14. Kongres Oftalmologi Nasional ke-52, Tampilan Bintik Merah Ceri di Makula dan Alkaptonuria: Laporan Kasus, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turki

    15. Kongres Oftalmologi Nasional ke-52, Komplikasi Langka pada Implantasi Deksametason Intravitreal: Migrasi Implan ke Ruang Anterior, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turki

    16. Kongres Oftalmologi Nasional ke-52, Efek Tetes Mata Koenzim Q10 pada Penyembuhan Luka Kornea dalam Pengobatan Keratitis Bakteri, Batur M, Seven E, Tekin S, Ozer MD, Presentasi lisan, November 2018, Antalya, Turki

    17. Kongres Euretina ke-19, Efek produksi humor aquous yang berkurang pada potensi pertumbuhan bakteri di mata kelinci, Batur M, Ozer M, Tekin S, Presentasi lisan, September 2019, Paris, Prancis

    18. Kongres Oftalmologi Nasional ke-53, Evaluasi fitur klinis pasien dengan hifema akibat trauma tumpul, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Presentasi lisan, November 2019, Antalya, Turki

    19. Kongres Oftalmologi Nasional ke-53, Kepatuhan terhadap terapi tetes mata dan hubungan kepatuhan dengan perkembangan pada pasien glaukoma, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turki

    20. Kongres Oftalmologi Nasional ke-53, Kehilangan penglihatan bilateral mendadak-sementara setelah pelepasan kateter venosa sentral, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turki

    21. Kongres Oftalmologi Nasional ke-53, Evaluasi klinis terapi fotokoagulasi laser Argon pada pasien dengan robekan retina, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turki

     

    22. Kongres Oftalmologi Nasional ke-53, Kerusakan makula akibat epilasi laser: laporan kasus, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turki

     

    23. Kongres Oftalmologi Nasional ke-53, Makulopati Fototoksik akibat Penggunaan Berlebihan Inframerah Iluminator Bersama Scope Penglihatan Malam Tangan, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turki

     

    24. Kongres Oftalmologi Nasional ke-54, Ophthalmoplegia internal setelah infeksi cacar air, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turki.

     

    Pengalaman Kerja :

    1. Studi Tahap II untuk Menganalisis Sarilumab dalam Uveitis Non-Infeksius (SARILNIUSATURN-Sanofi), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

    2. Efikasi Gevokizumab dalam Pengobatan Pasien dengan Uveitis Penyakit Behçet (EYEGUARD-A&C-Servier), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

    3. Studi Acak, Tertutup Ganda, Dikendalikan Plasebo tentang Efikasi Gevokizumab dalam Pengobatan Pasien dengan Uveitis Penyakit Behçet (EYEGUARD-B-Servier), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

     

    4. Studi 12 bulan, acak, tertutup ganda, dikendalikan semu, multicenter untuk mengevaluasi efikasi dan keamanan injeksi intravitreal ranibizumab 0,5 mg akibat edema makula akibat faktor pertumbuhan endotel vaskular (VEGF) (RFB002-Novartis), Peneliti sub-injeksi (Peneliti Utama: Prof. Dr. Nur Kir)

    5. Studi fase III multicenter, acak, tertutup ganda, dikendalikan semu untuk menilai efikasi dan keamanan lampalizumab yang diberikan secara intravitreal kepada pasien dengan atrofi geografis sekunder akibat degenerasi makula terkait usia (GX29176-Roche), Fotografer (Peneliti Utama: Prof. Dr. Nur Kir)

     

    Dipilih sebagai anggota aktif Asosiasi Oftalmologi Turki, Dewan Dokter Muda, 2020 - sekarang

     

  • Baca selengkapnya
Kunjungan dokter
Harga berdasarkan permintaan
Info

Mustafa Serkan Alemdar

  • 4.5 Baik 6 ulasan
  • 19 tahun pengalaman
  • Turquia, Antália, Medical Park Antalya Hospital Complex
  • Education and Specialization

    • 2006: Kocaeli University Faculty of Medicine
    • 2014: Akdeniz University Faculty of Medicine, Internal Medicine
    • 2018: Akdeniz University Faculty of Medicine, Medical Oncology

    Experience

    • 2006 - 2008: Konya Derebucak District Hospital
    • 2009 - 2015: Akdeniz University Hospital
    • 2015: Antalya Kaş State Hospital
    • 2015 - 2016: İnönü University Faculty of Medicine
    • 2016 - 2021: Akdeniz University Hospital
    • 2021 - 2023: Antalya Training and Research Hospital
  • Baca selengkapnya
Kunjungan dokter
Harga berdasarkan permintaan
Info

Ronit El Hasid

  • 4.5 Baik 153 ulasan
  • 37 tahun pengalaman
  • Israel, Telavive, Sourasky Medical Center (Ichilov)
  • Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.

  • Baca selengkapnya
Kunjungan dokter
Harga berdasarkan permintaan
Info

Dror Levin

  • 4.5 Baik 153 ulasan
  • 40 tahun pengalaman
  • Israel, Telavive, Sourasky Medical Center (Ichilov)
  • Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.

  • Baca selengkapnya
Kunjungan dokter
Harga berdasarkan permintaan
Info

Nichakorn Seehirunwong

  • 4.7 Sangat baik 3 ulasan
  • 20 tahun pengalaman
  • Tailândia, Banguecoque, Intrarat Hospital
  • Nichakorn Seehirunwong, M.D.

     

    Radiologist

     

    Graduated (M.D. From)

    Doctor of Medicine, Faculty of Medicine, Prince of Songkla University

    • Interpreting the results of medical imaging tests.
    • Comparing medical image findings with other examinations and tests.
    • Consulting with your referring healthcare provider (the provider who ordered the imaging tests) to help choose the proper imaging test and using test results to inform your medical care. Writing reports of results and diagnoses.
    • Recommending additional examinations or treatments when necessary.
    • Treating diseases by using radiation (radiation oncology) or imaging-guided procedures (interventional radiology). Performing or directing radiology staff to carry out imaging tests.

    Certificates

    Certificate of Diagnostic Radiology, Faculty of Medicine, Prince of Songkla University

     

    Current Positions

    Diagnostic Radiologist at Intrarat Hospital

  • Baca selengkapnya
Kunjungan dokter
Harga berdasarkan permintaan
Info

Nail Paksoy

  • 4.5 Baik 2 ulasan
  • 14 tahun pengalaman
  • akreditasi:
  • Turquia, Istambul, Medipol Bahçelievler Hospital

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Baca selengkapnya
Kunjungan dokter
Harga berdasarkan permintaan
Info

Tips Memilih Dokter dan Klinik yang Tepat: Rahasia Orang Dalam

Saat memilih dokter atau klinik, ingat hal-hal penting berikut:
Periksa kredensial
Verifikasi sertifikasi dari badan seperti ISAPS, JCI, dll.
Tinjau tingkat keberhasilan
Pilih dokter yang berpengalaman dalam perawatan yang Anda butuhkan.
Baca ulasan pasien
Baca ulasan Bookimed langsung dari pasien untuk mengetahui pengalaman mereka.
Pastikan komunikasi
Pilih klinik yang menyediakan dukungan bahasa untuk kelancaran pengobatan.
Tanyakan tentang layanan
Pastikan apakah mereka menyediakan akomodasi dan transfer, serta periksa biayanya.
Memilih klinik di luar negeri bisa membuat stres. Di Bookimed, dengan 800.000+ pasien telah dibantu, kami memahami kekhawatiran Anda. Kami tahu cara menemukan dokter terpercaya, opsi harga terbaik, dan solusi bahkan untuk kasus yang rumit. Kami siap membimbing Anda di setiap langkah.
Yan Matsiivskiy
Kepala Tim Koordinator Medis